REFRACTORY ANGINA
Clinical trials for REFRACTORY ANGINA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ANGINA trials appear
Sign up with your email to follow new studies for REFRACTORY ANGINA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own stem cells ease incurable chest pain?
Disease control OngoingThis trial tests whether injecting a patient's own bone marrow stem cells into the heart can improve exercise ability and reduce chest pain in people with severe, untreatable angina. About 343 participants will either receive the stem cell treatment or a sham procedure. The goal …
Matched conditions: REFRACTORY ANGINA
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Heart drug trial pulled before it even started
Symptom relief TerminatedThis was a planned Phase 2 study to test whether the drug IMB-1018972 could safely help people with refractory angina—chest pain that doesn't improve with standard treatments. The study aimed to measure exercise capacity, angina symptoms, and activity levels. However, the trial w…
Matched conditions: REFRACTORY ANGINA
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC